1
Xylometazoline During Nasal Flexible Bronchoscopy
Condition(s):BronchoscopyLast Updated:March 8, 2019Completed
Xylometazoline as an Intervention: 90 Clinical Trials
Hide Studies Not Open or Pending
2
Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis
Condition(s):Acute RhinosinusitisLast Updated:July 9, 2019Completed
3
Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:October 19, 2015Completed
4
Clinical and Translational Study of STA-9090
Condition(s):Colon Cancer; Rectal CancerLast Updated:October 19, 2015Completed
5
STA-9090(Ganetespib) in Metastatic Ocular Melanoma
Condition(s):Ocular MelanomaLast Updated:October 16, 2018Completed
6
Nasal Decongestion and Obstructive Sleep Apnea
Condition(s):Obstructive Sleep Apnea Syndrome; RhinitisLast Updated:December 21, 2009Completed
7
Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis
Condition(s):Acute RhinosinusitisLast Updated:July 10, 2018Completed
8
Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
Condition(s):Common ColdLast Updated:May 2, 2007Completed
9
STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
Condition(s):MelanomaLast Updated:March 1, 2017Terminated
10
Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer
Condition(s):Small Cell Lung CancerLast Updated:April 12, 2019Completed
11
STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer
Condition(s):Esophagogastric CancerLast Updated:March 20, 2018Completed
12
The Role of the Nose in Snoring and Sleep Apnea
Condition(s):Nasal Obstruction; Apnea, Obstructive SleepLast Updated:March 6, 2017Unknown status
13
STA-9090 in Patients With Advanced Hepatocellular Cancer
Condition(s):Hepatocellular CarcinomaLast Updated:April 23, 2018Completed
14
STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
Condition(s):Adenocarcinoma of the ProstateLast Updated:August 29, 2015Withdrawn
15
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Condition(s):Solid Tumor MalignanciesLast Updated:September 18, 2014Completed
16
Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Condition(s):Advanced Lung CancerLast Updated:February 25, 2019Active, not recruiting
17
The Influence of Inhaled Adrenalin Versus Decongestant as a Local Nasal Treatment in Bronchiolitis
Condition(s):BronchiolitisLast Updated:February 25, 2008Completed
18
Effect of the Nasal Provocation on the Breathing Style
Condition(s):Birch Pollen Allergy; Healthy Control SubjectsLast Updated:May 22, 2014Unknown status
19
A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
Condition(s):Nasal CongestionLast Updated:October 16, 2018Completed
20
Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
Condition(s):Vascular DementiaLast Updated:November 16, 2011Completed
21
Phase II Study of STA-2 in Patients With Chronic Stable Angina
Condition(s):Chronic Stable AnginaLast Updated:December 1, 2011Completed
22
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Condition(s):Non Small Cell Lung CancerLast Updated:September 18, 2014Completed
23
Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
Condition(s):Solid TumorsLast Updated:September 17, 2014Completed
24
A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain
Condition(s):Low Back PainLast Updated:October 11, 2018Active, not recruiting
25
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Condition(s):Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IV Pancreatic CancerLast Updated:June 23, 2014Terminated
26
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Condition(s):Solid TumorsLast Updated:September 17, 2014Unknown status
27
Evaluation of Safety of ZyComb® In Patients With Common Cold – ZIP 3000 (XY-005-IM)
Condition(s):Common ColdLast Updated:May 4, 2012Completed
28
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Condition(s):MelanomaLast Updated:January 31, 2014Terminated
29
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
Condition(s):Chronic Stable AnginaLast Updated:August 13, 2014Completed
30
STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders
Condition(s):AML; CML; MDS; Myeloproliferative DisordersLast Updated:September 17, 2014Completed
31
STA-5326 in Crohn’s Disease Patients
Condition(s):Crohn’s DiseaseLast Updated:June 23, 2005Completed
32
A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)
Condition(s):Gastrointestinal Stromal TumorLast Updated:February 11, 2016Completed
33
STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency
Condition(s):Common Variable ImmunodeficiencyLast Updated:June 30, 2017Completed
34
A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:January 31, 2014Completed
35
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
Condition(s):Hematological Malignancies; Leukemia; Lymphoma; Metastatic or Unresectable Solid TumorsLast Updated:December 3, 2008Completed
36
A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Blast-phase Chronic Myelogenous Leukemia; AML; ALL; CMLLast Updated:September 17, 2014Completed
37
The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn’s Disease
Condition(s):Crohn’s DiseaseLast Updated:June 30, 2017Completed
38
STA-4783 and Paclitaxel for Treatment of Solid Tumors
Condition(s):NeoplasmsLast Updated:March 5, 2014Completed
39
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn’s Disease
Condition(s):Crohn’s DiseaseLast Updated:December 3, 2008Completed
40
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn’s Disease
Condition(s):Crohn’s DiseaseLast Updated:December 3, 2008Completed
41
STA-21 Topical Efficacy on Psoriasis
Condition(s):PsoriasisLast Updated:January 12, 2010Completed
42
Study of STA-1 as an Add-on Treatment to Donepezil
Condition(s):Alzheimer DiseaseLast Updated:August 19, 2014Unknown status
43
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
Condition(s):MelanomaLast Updated:March 5, 2014Completed
44
A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes
Condition(s):Active, Moderate to Severe Rheumatoid ArthritisLast Updated:February 3, 2014Completed
45
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition(s):Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerLast Updated:August 19, 2018Completed
46
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
Condition(s):Soft Tissue SarcomaLast Updated:June 19, 2006Completed
47
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Condition(s):Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung CancerLast Updated:December 3, 2008Completed
48
Apixaban Validation Study – Additional Study on Fresh Samples
Condition(s):Anticoagulation With ApixabanLast Updated:March 8, 2018Completed
49
Determination of Fibrin Activity in Plasma on STA-R® Prototype
Condition(s):Blood Coagulation Disorders; Thrombotic Disorders; Hemorrhagic Disorders; TraumaLast Updated:August 29, 2018Recruiting
50
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Condition(s):Deep Venous Thrombosis; Pulmonary Embolism; D-dimerLast Updated:August 4, 2016Completed
51
Nasal Prep for Nasendoscopy in Children
Condition(s):Flexible NasendoscopyLast Updated:December 4, 2012Completed
52
Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD
Condition(s):Cognitive Behavioral Therapy; Autism Spectrum Disorder; Anxiety Disorders; Obsessive-Compulsive Disorder; Social Anxiety Disorder; Generalized Anxiety Disorder; Specific PhobiaLast Updated:September 30, 2019Active, not recruiting
53
The Adult Hemorrhagic Moyamoya Surgery Study
Condition(s):Moyamoya; StrokeLast Updated:February 13, 2016Active, not recruiting
54
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV; Non-small Cell Lung Cancer MetastaticLast Updated:November 4, 2015Terminated
55
Validation of Rivaroxaban Assay for US Registration
Condition(s):Patients Receiving Rivaroxaban TreatmentLast Updated:February 13, 2017Completed
56
To Compare Two Commonly Used Soft Tissue Grafting Techniques to Achieve Coronal Flap Advancement and Root Coverage
Condition(s):Gingival RecessionLast Updated:June 27, 2019Recruiting
57
Levofloxacin in Bacterial Rhinosinussitis
Condition(s):RhinosinusitisLast Updated:March 14, 2016Completed
58
Ganetespib Window of Opportunity Study in Head and Neck Cancers
Condition(s):Stage I Hypopharyngeal Squamous Cell Carcinoma; Stage I Laryngeal Squamous Cell Carcinoma; Stage I Oral Cavity Squamous Cell Carcinoma; Stage I Oropharyngeal Squamous Cell Carcinoma; Stage II Hypopharyngeal Squamous Cell Carcinoma; Stage II Laryngeal Squamous Cell Carcinoma; Stage II Oral Cavity Squamous Cell Carcinoma; Stage II Oropharyngeal Squamous Cell Carcinoma; Stage III Hypopharyngeal Squamous Cell Carcinoma; Stage III Laryngeal Squamous Cell Carcinoma; Stage III Oral Cavity Squamous Cell Carcinoma; Stage III Oropharyngeal Squamous Cell Carcinoma; Stage IVA Hypopharyngeal Squamous Cell Carcinoma; Stage IVA Laryngeal Squamous Cell Carcinoma; Stage IVA Oral Cavity Squamous Cell Carcinoma; Stage IVA Oropharyngeal Squamous Cell CarcinomaLast Updated:July 22, 2016Terminated
59
Computer Controlled Local Anesthesia in Children
Condition(s):Pain Perception of the New Device; The Pain Related Behavior; The Effectiveness of AnesthesiaLast Updated:September 1, 2015Completed
60
Non-invasive Mechanical Ventilation After Cardiac Surgery
Condition(s):Heart; Dysfunction Postoperative, Cardiac SurgeryLast Updated:October 21, 2011Completed
61
SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Condition(s):Malignant Peripheral Nerve Sheath Tumors (MPNST); SarcomaLast Updated:May 1, 2019Completed
62
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Condition(s):NeoplasmsLast Updated:March 2, 2018Terminated
63
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition(s):Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube Mucinous Adenocarcinoma; Fallopian Tube Serous Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fallopian Tube Undifferentiated Carcinoma; Ovarian Brenner Tumor; Ovarian Clear Cell Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Serous Adenocarcinoma; Ovarian Transitional Cell Tumor; Ovarian Undifferentiated Carcinoma; Primary Peritoneal Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaLast Updated:September 30, 2019Completed
64
Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Condition(s):Breast CancerLast Updated:December 10, 2018Completed
65
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
Condition(s):Non-Small-Cell Lung Adenocarcinoma; Non-small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV; Non-small Cell Lung Cancer MetastaticLast Updated:May 26, 2016Terminated
66
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Condition(s):Rectal CancerLast Updated:February 19, 2016Completed
67
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition(s):Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity CancerLast Updated:June 27, 2019Terminated
68
Home Mechanical Ventilation vs Home Oxygen Therapy in COPD
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:May 11, 2016Completed
69
Carotid Occlusion Surgery Study
Condition(s):Stroke; Ischemic Attack, Transient; Cerebral InfarctionLast Updated:March 24, 2012Terminated
70
Differential Diagnosis of STA-PSV in Thyrotoxicosis
Condition(s):Thyrotoxicosis; Peak Systolic Velocity of Superior Thyroid Artery; Thyroiditis; Graves DiseaseLast Updated:May 2, 2014Completed
71
Short-term Prednisone to Treat STA Study(SPTSS)
Condition(s):Subacute ThyroiditisLast Updated:May 18, 2015Completed
72
Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease
Condition(s):Moyamoya DiseaseLast Updated:January 29, 2019Recruiting
73
“Get up” – The Sleep Study in Oppegard
Condition(s):Sleep Initiation and Maintenance DisordersLast Updated:March 12, 2019Completed
74
Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome
Condition(s):Moyamoya Disease; Remote Ischemic PreconditioningLast Updated:August 21, 2018Completed
75
4″S” – Seasonal Symptoms Suppression Study
Condition(s):Seasonal Allergic RhinitisLast Updated:September 21, 2015Unknown status
76
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:October 8, 2015Completed
77
Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis
Condition(s):Intracranial Arterial Stenosis; Intracranial Atherosclerosis; Ischemic Stroke; Cerebral AngiogenesisLast Updated:May 8, 2019Completed
78
Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease
Condition(s):Moyamoya DiseaseLast Updated:December 2, 2016Unknown status
79
STAMCAR: A Prospective EC-IC Bypass Registry
Condition(s):Carotid OcclusionLast Updated:August 6, 2018Recruiting
80
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
Condition(s):HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:June 13, 2018Completed
81
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
Condition(s):Gastroesophageal Junction Adenocarcinoma; Malignant Neoplasm of the Cervical Esophagus; Malignant Neoplasm of the Thoracic Esophagus; Stage IIA Esophageal Cancer AJCC v7; Stage IIB Esophageal Cancer AJCC v7; Stage IIIA Esophageal Cancer AJCC v7; Stage IIIB Esophageal Cancer AJCC v7; Stage IIIC Esophageal Cancer AJCC v7Last Updated:July 22, 2019Completed
82
Study of Mechanisms of Emotion Regulation in Alcohol-abstinent Patients
Condition(s):Alcohol Use DisorderLast Updated:August 24, 2017Completed
83
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
Condition(s):Breast Cancer; HER-2 Positive Breast Cancer; Triple Negative Breast Cancer; ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentLast Updated:November 4, 2015Completed
84
Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery
Condition(s):Moyamoya DiseaseLast Updated:August 21, 2017Unknown status
85
Project 1: Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking
Condition(s):Smoking; Nicotine Dependence; Electronic Health Records; Translational ResearchLast Updated:June 20, 2019Completed
86
A Pilot Study of 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU or HDR Therapy
Condition(s):Prostate CancerLast Updated:May 14, 2019Recruiting
87
Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?
Condition(s):HemophiliaLast Updated:November 29, 2017Recruiting
88
Efficiency of Triple Antibiotic Paste, Ciprofloxacin/Propolis, Ciprofloxacin/Metronidazole, Propolis/Metronidazole Combinations on Revascularization Process of Immature Necrotic Maxillary Incisors of Patients 8-18 Years Old.
Condition(s):Dental Pulp Necrosis; Periapical Abscess; Root Canal InfectionLast Updated:May 25, 2018Completed
89
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Condition(s):Breast Carcinoma; Estrogen Receptor PositiveLast Updated:April 6, 2019Recruiting
90
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
Condition(s):Stage II Prostate Adenocarcinoma; Stage III Prostate Adenocarcinoma; Stage IV Prostate AdenocarcinomaLast Updated:December 11, 2018Recruiting